Resveratrol inhibits nonalcoholic fatty liver disease in rats

BACKGROUND: The prevalence of nonalcoholic fatty liver disease (NAFLD) is high. NAFLD is linked to obesity, diabetes mellitus, and hypertriglyceridemia. Approximately 20% of patients with NAFLD will eventually develop cirrhosis. Our purpose was to investigate whether resveratrol decreased hepatic st...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bujanda, Luis, Hijona, Elizabeth, Larzabal, Mikel, Beraza, Marta, Aldazabal, Pablo, García-Urkia, Nerea, Sarasqueta, Cristina, Cosme, Angel, Irastorza, Belen, González, Alberto, Arenas, Juan I
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2008
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2547101/
https://ncbi.nlm.nih.gov/pubmed/18782455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-230X-8-40
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak